1.
Vityala Yethindra, Ainura Dzhangazieva, Zhyldyz Kurzhunbaeva, Tugolbai Tagaev, Furquan Nazami. VYTR hypothesis for the prophylactic and therapeutic efficacy of GS-5734 treatment in humans with COVID-19. ijrps [Internet]. 2020Apr.1 [cited 2020Aug.11];11(SPL1):19-2. Available from: https://pharmascope.org/ijrps/article/view/2007